Cargando…
Discontinuation of Pegvaliase therapy during maternal PKU pregnancy and postnatal breastfeeding: A case report
Autores principales: | Rohr, Fran, Kritzer, Amy, Harding, Cary O., Viau, Krista, Levy, Harvey L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6957825/ https://www.ncbi.nlm.nih.gov/pubmed/31956506 http://dx.doi.org/10.1016/j.ymgmr.2019.100555 |
Ejemplares similares
-
Reinstitution of pegvaliase therapy during lactation
por: Rohr, Frances, et al.
Publicado: (2022) -
Nutrition management of PKU with pegvaliase therapy: update of the web-based PKU nutrition management guideline recommendations
por: Cunningham, Amy, et al.
Publicado: (2023) -
First 1.5 years of pegvaliase clinic: Experiences and outcomes
por: Sacharow, Stephanie, et al.
Publicado: (2020) -
Evidence- and consensus-based recommendations for the use of
pegvaliase in adults with phenylketonuria
por: Longo, Nicola, et al.
Publicado: (2018) -
Nutritional status of adults with phenylketonuria on pegvaliase: A 15-month prospective study
por: Viau, Krista, et al.
Publicado: (2023)